O
OrbiMed Portfolio holdings
AUM
$4.89B
1-Year Est. Return
87.75%
This Fund
S&P 500
1 Year Est. Return
+87.75%
AUM
$4.89B
AUM Growth
+$717M
(+17%)
Holding
126
Top Buys
| 1 | +$41.7M | |
| 2 | +$37.3M | |
| 3 | +$33.5M | |
| 4 |
HELP
Cybin Inc
HELP
|
+$24.7M |
| 5 |
Bruker
BRKR
|
+$23.5M |
Top Sells
| 1 | +$125M | |
| 2 | +$65.8M | |
| 3 | +$51.6M | |
| 4 |
Axsome Therapeutics
AXSM
|
+$38.9M |
| 5 |
SI-BONE Inc
SIBN
|
+$38M |
Sector Composition
| 1 | Healthcare | 99.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
RAPT Therapeutics
RAPT
$1.68B
| $55.6M | 1.14% |
1,642,891
+556,273
|
|
||
27
Corvus Pharmaceuticals
CRVS
$1.53B
| $55.2M | 1.13% |
7,165,006
|
|
||
28
United Therapeutics
UTHR
$21.7B
| $51.3M | 1.05% |
105,200
-9,700
|
|
||
|
ABVX
29
Abivax
ABVX
$9.59B
| $49.6M | 1.02% |
367,900
-12,100
|
|
||
30
Roivant Sciences
ROIV
$20.7B
| $47.5M | 0.97% |
2,190,907
-523,891
|
|
||
31
Crinetics Pharmaceuticals
CRNX
$4.21B
| $46.5M | 0.95% |
999,000
-100,000
|
|
||
|
32
Axsome Therapeutics
AXSM
$8.38B
| $46.2M | 0.95% |
253,121
-278,679
|
|
||
33
EyePoint Inc
EYPT
$1.45B
| $45.1M | 0.92% |
2,468,314
+672,314
|
|
||
|
RNAM
34
Avidity Biosciences
RNAM
$11.2B
| $44.7M | 0.91% |
619,530
-1,019,356
|
|
||
35
Neurocrine Biosciences
NBIX
$13.3B
| $44.6M | 0.91% |
314,240
-39,400
|
|
||
36
Dyne Therapeutics
DYN
$2.57B
| $43.1M | 0.88% |
2,202,184
-112,000
|
|
||
37
Bristol-Myers Squibb
BMY
$127B
| $41.8M | 0.86% |
+775,000
|
|
||
38
Pfizer
PFE
$157B
| $41.2M | 0.84% |
+1,652,900
|
|
||
39
Trevi Therapeutics
TRVI
$1.53B
| $39.9M | 0.82% |
3,190,700
-117,700
|
|
||
40
Neuropace
NPCE
$486M
| $37.2M | 0.76% |
2,406,335
-207,849
|
|
||
41
Ascendis Pharma
ASND
$14.3B
| $36.7M | 0.75% |
171,977
-19,928
|
|
||
42
Exact Sciences
EXAS
$19.7B
| $35.7M | 0.73% |
351,716
-642,900
|
|
||
43
Mineralys Therapeutics
MLYS
$2.32B
| $35.6M | 0.73% |
980,400
-489,094
|
|
||
44
Elevance Health
ELV
$70.6B
| $34.7M | 0.71% |
+99,100
|
|
||
45
Forte Biosciences
FBRX
$379M
| $32.6M | 0.67% |
1,196,955
|
|
||
46
Prelude Therapeutics
PRLD
$174M
| $31.6M | 0.65% |
10,909,256
|
|
||
|
HELP
47
Cybin Inc
HELP
$367M
| $31.4M | 0.64% |
+3,840,500
|
|
||
48
Oric Pharmaceuticals
ORIC
$1.31B
| $29.8M | 0.61% |
3,641,756
|
|
||
49
Krystal Biotech
KRYS
$8.06B
| $29.5M | 0.6% |
119,800
+17,055
|
|
||
50
Praxis Precision Medicines
PRAX
$9.34B
| $27.9M | 0.57% |
+94,500
|
|